Hemosil Protein S Activity Assay
by Instrumentation Laboratory CO
510(k) K102164Ref 0020302000
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number84269505665269J 08426950566526 | Date30 Apr 2024 | StatusActive |
| United States | GUDID listing GUDID | Number08426950566526 | Date23 Sep 2016 | StatusListed |
| United States | FDA 510(k)SESE 510(k) | NumberK102164 | Date17 Mar 2011 | StatusActive |
Certificates
EUDAMED lists no certificate for this device's Basic UDI-DI.
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade Name
- HemosIL Protein S Activity
- Generic Name
- Protein S IVD, kit, clotting
- Model / Ref / Catalog
- 0020302000 EUDAMED00020302000 GUDID
- Primary DI / UDI-DI
- 08426950566526
- Basic UDI-DI
- 84269505665269J
- Direct Marketing DI
- 08426950566526
- 510(k) Number
- FDA Product Code
- GGP
- EMDN Code
- W0103020608 Protein s activity
- GMDN Term
- Protein S IVD, kit, clotting
- Device Class
- Class B EUDAMEDClass II 510(k)GUDID
- Regulation
- 21 CFR Part 864.7290
- EU market of registration
- Italy
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | 510(k) | GUDID |
|---|---|---|---|
| Model / Reference | 0020302000 | — | 00020302000 |
| Device Class | Class B | Class II | Class II |
Overview
AI-generated summary, 18 Sep 2026
The Hemosil Protein S Activity Assay is a qualitative and quantitative factor deficiency test for coagulation, specifically designed to measure the functional activity of free Protein S. It falls under the classification of a coagulation functional assay, utilising automated analysis to assess the prolongation of prothrombin time in the presence of recombinant human tissue factor, synthetic phospholipids, calcium ions, and activated protein C.
This assay is intended for use on ACL TOP Family analyzers and is supplied as a reagent for laboratory testing. It is classified as a Class II medical device under FDA 510(k) clearance (K102164) and meets IVDR requirements. The assay is not described as single-use or reusable, nor is MRI safety or sterility explicitly stated in the provided data. It is regulated under the FDA’s 510(k) Traditional pathway and falls under the Hematology advisory committee classification.
Other devices from Instrumentation Laboratory Company
Questions
AI-generated answers, 18 Sep 2026
What is the Hemosil Protein S Activity Assay used for in a clinical setting?
The Hemosil Protein S Activity Assay is a coagulation functional test designed to measure the functional activity of free Protein S in blood. It helps identify deficiencies in Protein S, which can affect coagulation and may be relevant in diagnosing or monitoring conditions related to blood clotting disorders. The assay works by assessing how the presence of Protein S influences the prolongation of prothrombin time in a controlled laboratory setting.
Which analyzers are compatible with this assay, and how is it supplied?
This assay is specifically designed for use on Instrumentation Laboratory’s ACL TOP Family analyzers. It is supplied as a reagent kit intended for laboratory testing, meaning it is not a standalone device but rather a component used within the analyzer system to perform the Protein S activity measurement.
Is the Hemosil Protein S Activity Assay single-use or reusable, and what are its storage requirements?
The provided data does not explicitly state whether the assay is single-use or reusable. However, as a reagent for laboratory testing, it is typically designed for multiple uses within a single batch or vial, depending on the manufacturer’s instructions. Storage requirements are not detailed in the data, but reagents like this are generally stored according to the manufacturer’s guidelines, often at refrigerated temperatures (2–8°C) and protected from light until use.
What regulatory pathway was followed for the approval of this device, and which advisory committee was involved?
The Hemosil Protein S Activity Assay was cleared through the FDA’s 510(k) Traditional pathway, demonstrating substantial equivalence to a predicate device. The product was reviewed by the Hematology (HE) Advisory Committee, which evaluates hematology-related devices to ensure their safety and effectiveness for clinical use in diagnosing or monitoring blood-related conditions.
Properties
Other properties (17)
- Sterile: No
- Single Use: No
- Implantable: No
- Contains Latex: No
- Animal Tissues: No
- Microbial Substances: No
- Self Testing: No
- Near-Patient Testing: No
- Companion Diagnostics: No
- Surgical Instrument: No
- New Device: No
- Over-the-Counter: No
- Combination Product: No
- HCT/P: No
- Premarket Exempt: No
- Serial Number: No
- Manufacturing Date: No